Investigative Site US012 — Indianapolis, Indiana

Investigative Site US012 is a clinical research site located in Indianapolis, Indiana, United States 46260.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Investigative Site US012 has participated in 1 clinical trials.

Therapeutic areas: Warm Autoimmune Hemolytic Anemia (wAIHA).

Sponsors: Incyte Corporation.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigative Site US012?

Investigative Site US012 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigative Site US012 conducted?

Investigative Site US012 has 1 clinical trials on record. Their work covers Warm Autoimmune Hemolytic Anemia (wAIHA).

Is Investigative Site US012 accredited by Crixeo Health?

Investigative Site US012 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigative Site US012?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.